Dual PPAR α/γ Agonism Normalizes Lipoprotein Profile of Renal Dyslipidemia

Figure 1

Plasma lipid concentrations at baseline and after six-week treatment with 1 mg tesaglitazar o.d. (mean and standard error of the mean).

(a)

(b)

(c)

(d)